Vukaneos Pharma SRL
Vukaneos Pharma reported total assets of 52,741 € at the end of the 2022 financial year (annual accounts filed with the NBB on 30 Jun 2023).
The score of Vukaneos Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2022
Change 2019 → 2022: Total assets +211 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vukaneos Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
- Year ended 31 Dec 2020filed on 30 Jul 2021
- Year ended 31 Dec 2019filed on 14 Aug 2020
- Year ended 31 Dec 2018filed on 28 Aug 2019
Vukaneos Pharma's financial analysis
- Solvency43.1%sector median: 50.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vukaneos Pharma
Vukaneos Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0839.519.855
- VAT number
- BE0839519855
- Peppol
- Registered · 0208:0839519855 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Sep 2011
- Registered office
- 1435 Mont-Saint-Guibert
- Latest accounts
- 2022 · filed on 30 Jun 2023
- Activity
- Business and other management consultancy activities (NACE 70200)
Vukaneos Pharma (SRL) has been based in Mont-Saint-Guibert since 2011, active in: business and other management consultancy activities. For 2022, it reports a net profit of 11,722 € and equity of 22,728 €; its revenue is not published. Its solvency stands at 43.1%, below the median of its sector (50.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Vukaneos Pharma
Companies in the same business, of comparable size and area, outside its group.
- ARC Business and other management consultancy activities Buggenhout · balance sheet 53,282 €
- Crezca Business and other management consultancy activities Ghent · balance sheet 53,519 €
- Octopus Management Services Business and other management consultancy activities Ixelles · balance sheet 51,947 €
- "Solis Consultancy" Business and other management consultancy activities Beveren-Kruibeke-Zwijndrecht · balance sheet 51,859 €
- Perf4IT Entreprise Business and other management consultancy activities Forest · balance sheet 182,017 €
- ML Consulting Business and other management consultancy activities Beersel · balance sheet 51,370 €
- Multiversity Business and other management consultancy activities Lint · balance sheet 51,320 €
- HB Consulting & Management Business and other management consultancy activities Jette · balance sheet 51,267 €
Frequently asked questions about Vukaneos Pharma
What is the revenue of Vukaneos Pharma?
Vukaneos Pharma files its accounts in a format where revenue is optional: it is not published for 2022.
What is the VAT number of Vukaneos Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0839519855 for Vukaneos Pharma, if the company is VAT-registered. Its company number (CBE) is 0839.519.855.
Where is the registered office of Vukaneos Pharma?
According to the CBE register, the registered office of Vukaneos Pharma is in 1435 Mont-Saint-Guibert.
What is the equity of Vukaneos Pharma?
At the close of the 2022 financial year, the equity of Vukaneos Pharma amounts to 22,728 €, a solvency of 43.1% of total assets.
Who manages Vukaneos Pharma?
The register lists 1 active mandates at Vukaneos Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Vukaneos Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →